Nanosonics Ltd
ASX:NAN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.63
4.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nanosonics Ltd
Nanosonics Ltd
Cash & Cash Equivalents
Nanosonics Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nanosonics Ltd
ASX:NAN
|
Cash & Cash Equivalents
AU$23.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Polynovo Ltd
ASX:PNV
|
Cash & Cash Equivalents
AU$45.9m
|
CAGR 3-Years
81%
|
CAGR 5-Years
27%
|
CAGR 10-Years
55%
|
|
|
SDI Ltd
ASX:SDI
|
Cash & Cash Equivalents
AU$6.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Cash & Cash Equivalents
AU$30.8m
|
CAGR 3-Years
94%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Ansell Ltd
ASX:ANN
|
Cash & Cash Equivalents
$185.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-5%
|
|
|
Next Science Ltd
ASX:NXS
|
Cash & Cash Equivalents
$9.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Nanosonics Ltd
Glance View
Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company is headquartered in Sydney, New South Wales and currently employs 339 full-time employees. The company went IPO on 2007-05-17. The firm's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. The firm is focused on research, development and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generates sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. The firm's products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (ERP). trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.
See Also
What is Nanosonics Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
23.5m
AUD
Based on the financial report for Jun 30, 2024, Nanosonics Ltd's Cash & Cash Equivalents amounts to 23.5m AUD.
What is Nanosonics Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
15%
Over the last year, the Cash & Cash Equivalents growth was -1%. The average annual Cash & Cash Equivalents growth rates for Nanosonics Ltd have been 1% over the past three years , 13% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
